Literature DB >> 1864011

Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity.

N Lahat1, E Aghai, B Maroun, A Kinarty, M Quitt, P Froom.   

Abstract

We studied B cells from 18 patients with B-CLL, six of them with autoimmune haemolytic anaemia, for spontaneous secretion of IL-6. Our aim was to determine whether the increased incidence of autoimmune disease found in B-CLL patients is associated with enhanced spontaneous IL-6 secretion. IL-6 was measured by the effect of B cell supernatants on the proliferation of an IL-6 dependent plasmacytoma cell line T1165. The highest IL-6 values (7.4 +/- 1.8 U/ml) were measured in supernatants derived on day 3 of culture from lymphocytes of the six patients with B-CLL and concomitant autoimmune disease. The maximal IL-6 values for 10 patients with B-CLL only were 2.8 +/- 0.3 U/ml and for 10 age-matched controls, 0.8 +/- 0.3 U/ml (P less than 0.01, each group compared with the other). We conclude that there is an association between B-CLL, autoimmune disease and the spontaneous in vitro secretion of IL-6. Further studies are needed to determine whether the IL-6 secretion plays a role in the pathogenesis of autoimmune disease in patients with B-CLL.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864011      PMCID: PMC1535733          DOI: 10.1111/j.1365-2249.1991.tb05723.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Pure red-cell aplasia in patients with chronic lymphocytic leukemia.

Authors:  G Chikkappa; M H Zarrabi; M F Tsan
Journal:  Medicine (Baltimore)       Date:  1986-09       Impact factor: 1.889

Review 2.  Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.

Authors:  J Gordon; G Guy; L Walker; P Nathan; R Exley; M Clemens
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia.

Authors:  A Biondi; V Rossi; R Bassan; T Barbui; S Bettoni; M Sironi; A Mantovani; A Rambaldi
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

Review 4.  Peptide growth factors are multifunctional.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

5.  Induction of proliferation of B prolymphocytic leukemia cells by phorbol ester and native or recombinant interferon-gamma.

Authors:  R W Sauerwein; W G van der Meer; L A Aarden
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

6.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

7.  Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.

Authors:  J F Rossi; T Commes; J Grenier; M Jourdan; B Chichehian; B Klein
Journal:  Am J Hematol       Date:  1988-12       Impact factor: 10.047

8.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.

Authors:  M Kawano; T Hirano; T Matsuda; T Taga; Y Horii; K Iwato; H Asaoku; B Tang; O Tanabe; H Tanaka
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

9.  Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts.

Authors:  G Haegeman; J Content; G Volckaert; R Derynck; J Tavernier; W Fiers
Journal:  Eur J Biochem       Date:  1986-09-15

10.  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.

Authors:  A Zilberstein; R Ruggieri; J H Korn; M Revel
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  5 in total

1.  Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.

Authors:  Dagmar Hildebrand; Klaus Heeg; Katharina F Kubatzky
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 2.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

3.  Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop.

Authors:  R Burger; J Wendler; K Antoni; G Helm; J R Kalden; M Gramatzki
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

4.  Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Authors:  T Robak; A Wierzbowska; M Błasińska-Morawiec; A Korycka; J Z Błoński
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

5.  Chronic lymphocytic leukemia B-cell-derived TNFα impairs bone marrow myelopoiesis.

Authors:  Bryce A Manso; Jordan E Krull; Kimberly A Gwin; Petra K Lothert; Baustin M Welch; Anne J Novak; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  iScience       Date:  2020-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.